Dr. Rahimi is board certified in transplant hepatatology, gastroenterology and internal medicine. His clinical interests include chronic liver disease, liver cancer, liver failure, metabolic and autoimmune diseases of the liver, viral hepatitis, complications of cirrhosis and liver transplantation. Dr. Rahimi has authored several research articles on improving the outcomes of patients with advanced liver disease. Dr. Rahimi holds a Master of Science in Applied Physiology from Finch University of Health Sciences in North Chicago and medical degree from Chicago Medical School. While completing his internship and residency in Internal Medicine at the University of Virginia in Charlottesville, VA, he concurrently obtained a Master of Science in Clinical Research in the Department of Public Health. Upon relocating to Dallas, Dr. Rahimi completed two fellowships, the first in Gastroenterology at the University of Texas Southwestern Medical Center followed by a fellowship in Transplant Hepatology at Baylor University Medical Center, part of Baylor Scott & White Health, in Dallas.
Read more about Dr. Rahimi’s publications on
PubMed.gov and the
Baylor Health Sciences Library.
Read Dr. Rahimi's article,
"5 things you need to know about fatty liver disease (and how to reverse it)".
Dr. Rahimi is involved in a study around the use of statins in patients with advanced liver failure and cirrhosis. Read more
here.
Dr. Rahimi was recognized by
D Magazine as a Best Doctor for 2024 and 2025.
Read Dr. Rahimi's article,
"Can fatty liver be reversed? 5 common questions, answered."